Emmaus Life Sciences Reports 2019 Third Quarter Financial ResultsNovember 12, 2019
Net Revenues Increased 25% Year-Over-Year, Company Opens and Expands Class of Trade with Community Hematologists and Correctional Facilities
Read More
Net Revenues Increased 25% Year-Over-Year, Company Opens and Expands Class of Trade with Community Hematologists and Correctional Facilities
Read MoreVivozon, Inc. executes a stock purchase agreement for a total of $2.4 million.
Read MoreCompany Reports Highest Gross Sales Month of 2019 and Total Gross Sales of $7.0 Achieved in the Third Quarter.
Read MoreIssuance by the Indian Patent Office Further Bolsters Emmaus’ International Intellectual Property Portfolio
Read MoreEmmaus approved to have its common stock trade on the OTCQB marketplace.
Read More